|
|||||
|
|
The Activin/FLRG Pathway Associates with Poor COVID-19 Outcomes in Hospitalized Patients |
|
| Authors: | Megan McAleavy Qian Zhang Peter J Ehmann Jianing Xu Matthew F Wipperman Dharani Ajithdoss Li Pan Matthew Wakai Raphael Simonson Abhilash Gadi Adelekan Oyejide Sara C Hamon Anita Boyapati Lori G Morton Tea Shavlakadze Christos A Kyratsous David J Glass |
| Institution: | a Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA |
| Abstract: | |
| Keywords: | |